Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
Prashanth Rawla, Tagore Sunkara, Vinaya Gaduputi
World Journal of Oncology (2019) Vol. 10, Iss. 1, pp. 10-27
Open Access | Times Cited: 1915

Showing 1-25 of 1915 citing articles:

Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Talia Golan, Pascal Hammel, Michele Reni, et al.
New England Journal of Medicine (2019) Vol. 381, Iss. 4, pp. 317-327
Open Access | Times Cited: 1866
Pancreatic Cancer
Wungki Park, Akhil Chawla, Eileen M. O’Reilly
JAMA (2021) Vol. 326, Iss. 9, pp. 851-851
Open Access | Times Cited: 1117
PARP Inhibitors: Clinical Relevance, Mechanisms of Action and Tumor Resistance
Maddison Rose, Joshua T. Burgess, Kenneth J. O’Byrne, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 511
Photodynamic and Photothermal Therapies: Synergy Opportunities for Nanomedicine
Marta Overchuk, Robert Weersink, Brian C. Wilson, et al.
ACS Nano (2023) Vol. 17, Iss. 9, pp. 7979-8003
Open Access | Times Cited: 510
Chemoresistance in Pancreatic Cancer
Siyuan Zeng, Marina Pöttler, Bin Lan, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 18, pp. 4504-4504
Open Access | Times Cited: 504
Pancreatic cancer: A review of epidemiology, trend, and risk factors
Jian-Xiong Hu, Chengfei Zhao, Chen WenBiao, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 27, pp. 4298-4321
Open Access | Times Cited: 381
Liver metastases
Diamantis I. Tsilimigras, Pnina Brodt, Pierre–Alain Clavien, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Closed Access | Times Cited: 342
Role of microbiota-derived short-chain fatty acids in cancer development and prevention
Rasoul Mirzaei, Azam Afaghi, Sajad Babakhani, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 139, pp. 111619-111619
Open Access | Times Cited: 291
m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling
Bo Tang, Yihua Yang, Min Kang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 259
Microbiota in pancreatic health and disease: the next frontier in microbiome research
Ryan M. Thomas, Christian Jobin
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 17, Iss. 1, pp. 53-64
Closed Access | Times Cited: 251
The impact of pre- and post-image processing techniques on deep learning frameworks: A comprehensive review for digital pathology image analysis
Massimo Salvi, U. Rajendra Acharya, Filippo Molinari, et al.
Computers in Biology and Medicine (2020) Vol. 128, pp. 104129-104129
Open Access | Times Cited: 251
Pancreatic Cancer: A Review of Risk Factors, Diagnosis, and Treatment
Zhiyu Zhao, Wei Liu
Technology in Cancer Research & Treatment (2020) Vol. 19
Open Access | Times Cited: 240
Cell death in pancreatic cancer: from pathogenesis to therapy
Xin Chen, Herbert J. Zeh, Rui Kang, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 11, pp. 804-823
Closed Access | Times Cited: 238
Burden of Pancreatic Cancer: From Epidemiology to Practice
Natalia Khalaf, Hashem B. El‐Serag, Hannah R. Abrams, et al.
Clinical Gastroenterology and Hepatology (2020) Vol. 19, Iss. 5, pp. 876-884
Open Access | Times Cited: 233
The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives
Shun Wang, Yan Zheng, Yang Feng, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 231
Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome
Ziying Zhang, Haosheng Tang, Peng Chen, et al.
Signal Transduction and Targeted Therapy (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 207
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
Zev A. Wainberg, Davide Melisi, Teresa Macarulla, et al.
The Lancet (2023) Vol. 402, Iss. 10409, pp. 1272-1281
Open Access | Times Cited: 199
A faecal microbiota signature with high specificity for pancreatic cancer
Ece Kartal, Thomas Schmidt, Esther Molina‐Montes, et al.
Gut (2022) Vol. 71, Iss. 7, pp. 1359-1372
Open Access | Times Cited: 185
The pancreatic cancer genome revisited
Akimasa Hayashi, Jungeui Hong, Christine A. Iacobuzio‐Donahue
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 7, pp. 469-481
Closed Access | Times Cited: 152
The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis
Adile Orhan, Rasmus Peuliche Vogelsang, Malene Broholm Andersen, et al.
European Journal of Cancer (2020) Vol. 132, pp. 71-84
Closed Access | Times Cited: 139
Treatment landscape of metastatic pancreatic cancer
Sara De Dosso, Alexander Siebenhüner, Thomas Winder, et al.
Cancer Treatment Reviews (2021) Vol. 96, pp. 102180-102180
Closed Access | Times Cited: 137
RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential
Jianwei Qu, Haimeng Yan, Yifan Hou, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 137
Exercise-induced engagement of the IL-15/IL-15Rα axis promotes anti-tumor immunity in pancreatic cancer
Emma Kurz, Carolina Hirsch, Tanner C. Dalton, et al.
Cancer Cell (2022) Vol. 40, Iss. 7, pp. 720-737.e5
Open Access | Times Cited: 135
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Hedy L. Kindler, Pascal Hammel, Michele Reni, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 34, pp. 3929-3939
Open Access | Times Cited: 132
Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer
Daniel Cui Zhou, Reyka G. Jayasinghe, Siqi Chen, et al.
Nature Genetics (2022) Vol. 54, Iss. 9, pp. 1390-1405
Open Access | Times Cited: 132
Page 1 - Next Page

Scroll to top